Intimation regarding Closure of Trading window for the quarter ended September 30, 2026

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: September 25, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Intimation regarding closure of Trading Window In accordance with the Company’s Code of Conduct for Prohibition of Insider Trading and in compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT Regulations”) the Trading Window for dealing in the securities of the Company shall be closed with effect from Thursday, October 1, 2026, till 48 hours from the date of declaration of financial results of the Company for the quarter and half year ending September 30, 2026. The date of Board Meeting for declaration of financial results of the Company for the quarter and half year ending September 30, 2026 will be intimated in due course. We request you to take the above information on your records. Thanking You, Yours Faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No: A57415 Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91- 22-20870033